697 related articles for article (PubMed ID: 18446657)
1. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
Durnwald CP; Landon MB
J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
[TBL] [Abstract][Full Text] [Related]
2. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
[TBL] [Abstract][Full Text] [Related]
3. Survey of glargine use in 115 pregnant women with Type 1 diabetes.
Gallen IW; Jaap A; Roland JM; Chirayath HH
Diabet Med; 2008 Feb; 25(2):165-9. PubMed ID: 18215174
[TBL] [Abstract][Full Text] [Related]
4. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study.
Balani J; Hyer SL; Rodin DA; Shehata H
Diabet Med; 2009 Aug; 26(8):798-802. PubMed ID: 19709150
[TBL] [Abstract][Full Text] [Related]
6. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
[TBL] [Abstract][Full Text] [Related]
7. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
[TBL] [Abstract][Full Text] [Related]
8. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
10. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
Fang YM; MacKeen D; Egan JF; Zelop CM
J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
[TBL] [Abstract][Full Text] [Related]
11. Use of insulin glargine during pregnancy: a case-control pilot study.
Price N; Bartlett C; Gillmer M
BJOG; 2007 Apr; 114(4):453-7. PubMed ID: 17261126
[TBL] [Abstract][Full Text] [Related]
12. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison.
Moore LE; Briery CM; Clokey D; Martin RW; Williford NJ; Bofill JA; Morrison JC
J Reprod Med; 2007 Nov; 52(11):1011-5. PubMed ID: 18161398
[TBL] [Abstract][Full Text] [Related]
13. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
14. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?
Lapolla A; Dalfrà MG; Fedele D
Diabetes Metab Res Rev; 2005; 21(3):241-52. PubMed ID: 15818714
[TBL] [Abstract][Full Text] [Related]
15. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.
Wyatt JW; Frias JL; Hoyme HE; Jovanovic L; Kaaja R; Brown F; Garg S; Lee-Parritz A; Seely EW; Kerr L; Mattoo V; Tan M;
Diabet Med; 2005 Jun; 22(6):803-7. PubMed ID: 15910635
[TBL] [Abstract][Full Text] [Related]
16. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents.
Ekpebegh CO; Coetzee EJ; van der Merwe L; Levitt NS
Diabet Med; 2007 Mar; 24(3):253-8. PubMed ID: 17305787
[TBL] [Abstract][Full Text] [Related]
17. Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes.
Lepercq J; Jacqueminet S; Hieronimus S; Timsit J; Grimaldi A
Diabetes Metab; 2010 Jun; 36(3):209-12. PubMed ID: 20188617
[TBL] [Abstract][Full Text] [Related]
18. Insulin lispro: new preparation. Faster acting.
Prescrire Int; 1998 Jun; 7(35):67-8. PubMed ID: 10342918
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients.
Dudhbhai M; Lim L; Bombard A; Juliard K; Meenakshi B; Trachelenberg Y; Weiner Z
Am J Obstet Gynecol; 2006 May; 194(5):e42-5. PubMed ID: 16647897
[TBL] [Abstract][Full Text] [Related]
20. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.
Ramos GA; Jacobson GF; Kirby RS; Ching JY; Field DR
J Perinatol; 2007 May; 27(5):262-7. PubMed ID: 17363911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
